Published in Cancer Med on October 31, 2013
Human papillomavirus (HPV) genome status & cervical cancer outcome - A retrospective study. Indian J Med Res (2015) 0.81
Transcriptome-wide signatures of tumor stage in kidney renal clear cell carcinoma: connecting copy number variation, methylation and transcription factor activity. Genome Med (2014) 0.81
Profiling of Discrete Gynecological Cancers Reveals Novel Transcriptional Modules and Common Features Shared by Other Cancer Types and Embryonic Stem Cells. PLoS One (2015) 0.80
Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients. PLoS One (2016) 0.77
Integrated network analysis and logistic regression modeling identify stage-specific genes in Oral Squamous Cell Carcinoma. BMC Med Genomics (2015) 0.76
Multiple criteria optimization joint analyses of microarray experiments in lung cancer: from existing microarray data to new knowledge. Cancer Med (2015) 0.76
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med (2004) 41.02
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res (2001) 8.34
Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci (2003) 5.26
Cancer mortality in India: a nationally representative survey. Lancet (2012) 4.30
Human papillomavirus--the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer (1996) 2.91
Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A (1998) 2.61
Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res (1999) 2.49
Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J (1998) 2.34
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer. Breast Cancer Res (2008) 2.09
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer. Hum Mol Genet (2004) 2.05
Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clin Cancer Res (2003) 1.96
DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem (1998) 1.65
Gene expression pattern associated with radiotherapy sensitivity in cervical cancer. Cancer J (2006) 1.57
Osteopontin is a marker for cancer aggressiveness and patient survival. Br J Cancer (2010) 1.54
Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells. Oncotarget (2011) 1.39
Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res (2003) 1.33
Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer (2006) 1.32
Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer (2011) 1.24
Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Res (2007) 1.17
Discovery of prostate cancer biomarkers by microarray gene expression profiling. Expert Rev Mol Diagn (2010) 1.16
Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. Clin Invest Med (2008) 1.15
Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells. PLoS One (2012) 1.12
Gene expression in early stage cervical cancer. Gynecol Oncol (2008) 1.08
ATF2 confers radiation resistance to human melanoma cells. Oncogene (1998) 1.07
PRC1 controls spindle polarization and recruitment of cytokinetic factors during monopolar cytokinesis. Mol Biol Cell (2012) 1.02
Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties. Oncogene (2011) 1.01
A 7 gene expression score predicts for radiation response in cancer cervix. BMC Cancer (2009) 0.96
Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer (1993) 0.95
DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer. Oncogene (2010) 0.94
Expression of Ku80 in cervical cancer correlates with response to radiotherapy and survival. Am J Clin Oncol (2003) 0.93
Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma. Oncotarget (2012) 0.93
Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer. Int J Gynecol Cancer (2008) 0.93
Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer. Eur J Obstet Gynecol Reprod Biol (2006) 0.92
Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol (2008) 0.92
Genome wide expression analysis in HPV16 cervical cancer: identification of altered metabolic pathways. Infect Agent Cancer (2007) 0.91
Searching for pathogenic gene functions to cervical cancer. Gynecol Oncol (2004) 0.90
Host deficiency in Vav2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo. Mol Cancer Res (2009) 0.89
Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia. BMC Genomics (2008) 0.89
Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer (2002) 0.88
p53, Bcl-2, PCNA expression, and apoptotic rates during cervical tumorigenesis. Ann N Y Acad Sci (2003) 0.87
Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. Blood (2012) 0.86
Frequent amplification of CENPF, GMNN and CDK13 genes in hepatocellular carcinomas. PLoS One (2012) 0.86
Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines. Cancer Genet Cytogenet (2008) 0.84
BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer. J Oncol (2010) 0.82
Inhibitory effects of adenovirus mediated COX-2, Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo. Int J Oncol (2009) 0.79
The effect of JDP2 and ATF2 on the epithelial-mesenchymal transition of human pancreatic cancer cell lines. Pathol Oncol Res (2011) 0.78
Imbalanced expression of mitogen-activated protein kinase phosphatase-1 and phosphorylated extracellular signal-regulated kinases in lung squamous cell carcinoma. J Zhejiang Univ Sci B (2011) 0.78
Identification of a 7-gene signature that predicts relapse and survival for early stage patients with cervical carcinoma. Med Oncol (2012) 0.78
Role of cell cycle biomarkers in human papillomavirus related uterine lesions. Curr Pharm Des (2013) 0.76
The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (2002) 18.30
Transcriptome sequencing to detect gene fusions in cancer. Nature (2009) 11.63
Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res (2004) 9.99
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science (2008) 7.59
Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci U S A (2009) 5.30
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med (2010) 4.81
Expressed pseudogenes in the transcriptional landscape of human cancers. Cell (2012) 4.22
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. Cancer Res (2008) 2.87
A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol (2008) 2.83
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med (2011) 2.77
Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res (2007) 2.14
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging (2011) 1.82
Management of renal cell carcinoma with solitary metastasis. World J Surg Oncol (2005) 1.72
A comparison of single molecule and amplification based sequencing of cancer transcriptomes. PLoS One (2011) 1.44
C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol (2004) 1.34
Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer. Mol Cell (2012) 1.34
Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J Cancer Res Ther (2011) 1.26
Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol (2012) 1.26
RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res Treat (2004) 1.25
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J Pathol (2014) 1.19
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response. Proc Natl Acad Sci U S A (2013) 1.19
EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy. PLoS One (2013) 1.18
Dosimetric evaluation of rectum and bladder using image-based CT planning and orthogonal radiographs with ICRU 38 recommendations in intracavitary brachytherapy. J Med Phys (2008) 1.16
Characterization of bone metastases from rapid autopsies of prostate cancer patients. Clin Cancer Res (2011) 1.16
Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients. Head Neck (2008) 1.14
Outlier kinase expression by RNA sequencing as targets for precision therapy. Cancer Discov (2013) 1.13
Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis (2007) 1.12
A rare case of primary gastric plasmacytoma: an unforeseen surprise. J Cancer Res Ther (2011) 1.09
Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer. Neoplasia (2012) 1.08
'Plan of the day' adaptive radiotherapy for bladder cancer using helical tomotherapy. Radiother Oncol (2011) 1.05
Hepatic resection for metastasis from adenoid cystic carcinoma of parotid gland. Indian J Gastroenterol (2005) 1.05
Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.03
Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (2002) 1.03
Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma? J Neurooncol (2012) 0.98
Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases. Radiother Oncol (2010) 0.96
HPV genotyping and site of viral integration in cervical cancers in Indian women. PLoS One (2012) 0.95
Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches. Acta Oncol (2009) 0.95
Inter-application variation of dose and spatial location of D(2cm(3)) volumes of OARs during MR image based cervix brachytherapy. Radiother Oncol (2013) 0.93
Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas. Neuro Oncol (2013) 0.93
Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer (2005) 0.92
Proton sponge trick for pH-sensitive disassembly of polyethylenimine-based siRNA delivery systems. Bioconjug Chem (2010) 0.92
Clinico-pathological spectrum of primary ovarian malignant mixed mullerian tumors (OMMMT) from a tertiary cancer institute: A series of 27 cases. Indian J Pathol Microbiol (2014) 0.92
Perioperative interstitial brachytherapy for soft tissue sarcomas: prognostic factors and long-term results of 155 patients. Ann Surg Oncol (2006) 0.91
Clinicopathological and prognostic implications of genetic alterations in oral cancers. Oncol Lett (2011) 0.90
Polymorphisms in GSTM1 and XPD genes predict clinical outcome in advanced oral cancer patients treated with postoperative radiotherapy. Mol Carcinog (2011) 0.88
Proteomic profiling of cancer of the gingivo-buccal complex: Identification of new differentially expressed markers. Proteomics Clin Appl (2009) 0.88
Loss of keratin 8 phosphorylation leads to increased tumor progression and correlates with clinico-pathological parameters of OSCC patients. PLoS One (2011) 0.88
Influence of genetic polymorphisms on frequency of micronucleated buccal epithelial cells in leukoplakia patients. Oral Oncol (2010) 0.87
Monthly palliative pelvic radiotherapy in advanced carcinoma of uterine cervix. J Cancer Res Ther (2007) 0.86
Multiple pathway-based genetic variations associated with tobacco related multiple primary neoplasms. PLoS One (2012) 0.86
Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Head Neck (2009) 0.85
Genotype, phenotype and cancer: role of low penetrance genes and environment in tumour susceptibility. J Biosci (2005) 0.85
Evidence for the presence of high risk human papillomavirus in retinoblastoma tissue from nonfamilial retinoblastoma in developing countries. Pediatr Blood Cancer (2011) 0.85
Evaluation of diffusion-weighted imaging as a predictive marker for tumor response in patients undergoing chemoradiation for postoperative recurrences of cervical cancer. J Cancer Res Ther (2012) 0.84
N-terminal PDZ-like domain of chromatin organizer SATB1 contributes towards its function as transcription regulator. J Biosci (2011) 0.84
Glutathione S-transferase M1 or T1 null genotype as a risk factor for developing multiple primary neoplasms in the upper aero-digestive tract, in Indian males using tobacco. Oral Oncol (2004) 0.84
Dose variation during hypofractionated image-guided radiotherapy for prostate cancer: planned versus delivered. J Cancer Res Ther (2011) 0.83
Factors affecting the quality of voice in the early glottic cancer treated with radiotherapy. Radiother Oncol (2008) 0.83
Clinical outcome of 36 male patients with primary urethral carcinoma: a single center experience. Int J Urol (2006) 0.83
Expression of enhancing factor/phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis. Oncogene (2003) 0.82
Human papillomavirus genotyping by multiplex pyrosequencing in cervical cancer patients from India. J Biosci (2008) 0.82
Mesonephric adenocarcinoma (endometrioid type) of endocervix with diffuse mesonephric hyperplasia involving cervical wall and myometrium: an unusual case report. Indian J Pathol Microbiol (2013) 0.81
Principles of radiation therapy in low-resource and well-developed settings, with particular reference to cervical cancer. Int J Gynaecol Obstet (2012) 0.81
PCNA and anti-apoptotic Mcl-1 proteins predict disease-free survival in oral cancer patients treated with definitive radiotherapy. Oral Oncol (2010) 0.81
Pathology of gallbladder carcinoma: current understanding and new perspectives. Pathol Oncol Res (2015) 0.81
Human papillomavirus (HPV) genome status & cervical cancer outcome - A retrospective study. Indian J Med Res (2015) 0.81
The European Organization for Research and Treatment of Cancer prostate-specific quality of life module (PR-25) in Hindi and Marathi: translation and pilot testing process. J Cancer Res Ther (2008) 0.81
Establishment & characterization of lymphoblastoid cell lines from patients with multiple primary neoplasms in the upper aero-digestive tract & healthy individuals. Indian J Med Res (2012) 0.81
Metastasis of squamous cell carcinoma of the oral tongue is associated with down-regulation of epidermal fatty acid binding protein (E-FABP). Oral Oncol (2006) 0.80
Clinical application of a OneDose MOSFET for skin dose measurements during internal mammary chain irradiation with high dose rate brachytherapy in carcinoma of the breast. Phys Med Biol (2006) 0.80
Estimation of risk of radiation-induced carcinogenesis in adolescents with nasopharyngeal cancer treated using sliding window IMRT. Radiother Oncol (2007) 0.80
Balloon cell melanoma of the anal canal: a wolf in sheep's clothing? J Cancer Res Ther (2014) 0.80
Interstitial brachytherapy for childhood soft tissue sarcoma. Pediatr Blood Cancer (2007) 0.80
Squamous cell carcinoma of base of tongue in a patient with Fanconi's anemia treated with radiation therapy: case report and review of literature. Head Neck (2010) 0.80
HDR brachytherapy combined with 3-D conformal vs. IMRT in left-sided breast cancer patients including internal mammary chain: comparative analysis of dosimetric and technical parameters. J Appl Clin Med Phys (2005) 0.80
Mode of cell death associated with adenovirus-mediated suicide gene therapy in HNSCC tumor model. Anticancer Res (2011) 0.79
Bcl-xL protein: predictor of complete tumor response in patients with oral cancer treated with curative radiotherapy. Head Neck (2012) 0.79
Consensus meeting and update on existing guidelines for management of cervical cancer with special emphasis on the practice in developing countries, including India: The expert panel at the 8(th) annual women's cancer initiative Tata Memorial Hospital Conference 2010-11. Indian J Med Paediatr Oncol (2012) 0.79
Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale. Int J Gynecol Cancer (2016) 0.78
Treatment planning comparison of electron arc therapy and photon intensity modulated radiotherapy for Askin's tumor of chest wall. Radiother Oncol (2007) 0.78
Females with paired occurrence of cancers in the UADT and genital region have a higher frequency of either Glutathione S-transferase M1/T1 null genotype. J Carcinog (2005) 0.78
Comparison of IPSA with dose-point optimization and manual optimization for interstitial template brachytherapy for gynecologic cancers. Brachytherapy (2010) 0.78
Helical tomotherapy-based hypofractionated radiotherapy for prostate cancer: a report on the procedure, dosimetry and preliminary clinical outcome. J Cancer Res Ther (2013) 0.78
Inter and intraobserver variation in gross tumor delineation on megavoltage CT images in patients undergoing tomotherapy-based image-guided radiotherapy for postoperative vault recurrences. J Cancer Res Ther (2011) 0.77
Chemoradiation for unresectable gall bladder cancer: time to review historic nihilism? J Gastrointest Cancer (2011) 0.77